ECE2016 Eposter Presentations Growth hormone IGF axis - basic (12 abstracts)
High normal TSH – risk factor for subclinical hypothyroidism in GH treatement for pituitary dwarfism?
Alina Daniela Belceanu 1 , Anamaria Bursuc 1 , Ioana Armasu 1 , Georgiana Andreea Constantinescu 1 , Iulia Crumpei 1 , Letitia Leustean 1 , Mihaela Anton 2 & Carmen Vulpoi 1
1University of Medicine and Pharmacy “Gr. T. Popa”, Department of Endocrinology, Iasi, Romania; 2Department of Endocrinology, Bacau, Romania.
Background: Normal thyroid function is necessary for the optimal effect of recombinant growth hormone (rhGH) on growth rate. GH therapy in children with GH deficiency (GHD) has yielded conflicting results concerning its impact on thyroid function. Data about patients developing subclinical hypothyroidism (SH) are scanty, but it is thought to be associated with impairment of metabolic profile and lower growth response.
Objective: To evaluate the effect of rhGH administration on TSH tertiles and FT4, the frequency of SH, as well as to assess its influence on therapy effectiveness.
Method: We reviewed the cases of 75 children (59 boys, 16 girls, aged 4−14) with pituitary dwarfism. Clinical and hormonal data, as well as radiographic bone assessments were documented at the beginning, 6 months and after first year of treatment.
Results: At therapy onset, all patients had the height below −2.5 SD (mean −3.2), delayed bone age, decreased or low normal IGF1 and normal thyroid function. After one year of therapy, SH was the only impairment in thyroid function in 12 patients (16%). The risk of SH was increased among subjects with the highest tertile TSH as compared with subjects with the lowest tertile (P<0.05). Despite similar IGF1 secretion increase, the improvement of height velocity was significantly lower in children with SH (0.65 cm/month) than in those who remained euthyroid (0.88 cm/month, P<0.05). An increase in IGF1 levels was associated with increasing levels of TSH in SH patients and led in four cases to administration of L−T4 substitution.
Conclusion: The incidence of SH during the first year of rhGH treatment in children with GHD and the influence on the growth rate should be taken into account, as it may worsen the growth response. Our findings suggest that suboptimal thyroid function increases vulnerability to the occurrence of SH in children treated with rhGH, needing a closer monitoring.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more